Weighing a regenerative care plan

What kind of product is being offered?

Get the exact product name first. Then separate what was reviewed, who makes it, and what the label says it is for.

What is the FDA?

FDA is short for Food and Drug Administration; it is the U.S. drug agency.

Ask about the product itself.
Keep a clinic’s description separate from the product’s review.

Compare the kinds of product.

Read them together, or focus on the kind named in an offer.

Approved medicine

As of September 2026, an FDA-approved medicine had been reviewed for a named purpose.

Which named use was reviewed?
Does the proposal match that use?
Where is the product’s full label?

Made-to-order medicine

Compounded medicines lacked FDA approval as of September 2026; they were prepared to order.

Why is a custom product needed?
Which pharmacy will prepare it?
What law allows this pharmacy to make this medicine for me?

Research-labelled product

FDA warning letters reviewed in September 2026 described sellers offering people unapproved medicines even though labels said “for research use only”.

Is the page also making claims about treating people?
Does the label contradict the care being offered?
Where is the care plan from the person treating you?

A prescription does not answer every question.

Compounding can meet a need an approved drug cannot meet, but it still has to satisfy the compounding rules, as of September 2026.

Get the ingredient name in writing, and ask whether the medicine is a pill, an injection, or something else.
Ask for the pharmacy’s name.
Ask why the person writing the prescription chose this medicine for you.

Does it match an approved product?

As of September 2026, FDA said it was misleading to describe a made-to-order medicine as the same as an approved drug or as an approved copy of it.

A shared ingredient name is not a full answer.
Ask which finished product has approval.
Ask what evidence supports a claim of equal results.